Publication & Citation Trends
Publications
0 total
FIRST-IN-HUMAN SINGLE-ASCENDING-DOSE STUDY OF IW-1973, A NEW SOLUBLE GUANYLATE CYCLASE STIMULATOR OA
Cited by 4
Semantic Scholar
IW-3718, a Novel Gastric-Retentive Bile Acid Sequestrant, Improved Symptoms of Refractory GERD in a Double-Blind, Placebo-Controlled Phase 2a Study: 1661
Cited by 2
Semantic Scholar
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial OA
Cited by 69
Semantic Scholar
Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials: 1759
Cited by 0
Semantic Scholar
Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C OA
Cited by 16
Semantic Scholar
Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea: Presidential Poster: 1791
Cited by 6
Semantic Scholar
The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials OA
Cited by 30
Semantic Scholar
PWE-166 Is Response To Linaclotide After 4 Weeks Of Treatment Predictive Of 12-week Improvement? OA
Cited by 1
Semantic Scholar
Research Topics
Gastrointestinal motility and disorders
(50)
Intestinal Malrotation and Obstruction Disorders
(17)
Congenital gastrointestinal and neural anomalies
(15)
Gastroesophageal reflux and treatments
(10)
Diabetes Treatment and Management
(8)
Affiliations
Beth Israel Deaconess Medical Center
Mayo Clinic
Ironwood Pharmaceuticals (United States)
University of Pittsburgh
University of California, San Francisco